These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 6181867

  • 1. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G.
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [Abstract] [Full Text] [Related]

  • 2. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R.
    Cancer Treat Rep; 1984 Nov; 68(7-8):947-51. PubMed ID: 6204754
    [Abstract] [Full Text] [Related]

  • 3. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Santoro A, Viviani S, Villarreal CJ, Bonfante V, Delfino A, Valagussa P, Bonadonna G.
    Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
    [Abstract] [Full Text] [Related]

  • 4. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P.
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA.
    J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796
    [Abstract] [Full Text] [Related]

  • 6. Third-line salvage chemotherapy in Hodgkin's disease.
    Bonadonna G, Viviani S, Valagussa P, Bonfante V, Santoro A.
    Semin Oncol; 1985 Mar 15; 12(1 Suppl 2):23-5. PubMed ID: 2579440
    [Abstract] [Full Text] [Related]

  • 7. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Diehl V, Fuchs M, GHSG.
    Transfus Apher Sci; 2007 Aug 15; 37(1):37-41. PubMed ID: 17714996
    [Abstract] [Full Text] [Related]

  • 8. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 15; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 9. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

  • 10. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar 20; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 11. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG.
    Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661
    [Abstract] [Full Text] [Related]

  • 12. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
    Bonadonna G, Zucali R, De Lena M, Valagussa P.
    Cancer Treat Rep; 1977 Aug 06; 61(5):769-77. PubMed ID: 70270
    [No Abstract] [Full Text] [Related]

  • 13. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K, Utsumi M, Shimoyama M.
    Gan To Kagaku Ryoho; 1998 Dec 06; 25(14):2202-9. PubMed ID: 9881076
    [Abstract] [Full Text] [Related]

  • 14. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH, Corder MP.
    Cancer Treat Rep; 1978 Mar 06; 62(3):363-7. PubMed ID: 77188
    [No Abstract] [Full Text] [Related]

  • 15. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL.
    Cancer J Sci Am; 1995 Mar 06; 1(4):267-73. PubMed ID: 9166487
    [Abstract] [Full Text] [Related]

  • 16. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M.
    Clin Ter; 2001 Jan 15; 152(3):203-6. PubMed ID: 11692542
    [No Abstract] [Full Text] [Related]

  • 19. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM, Colonna P.
    J Clin Oncol; 1998 Jun 15; 16(6):2283. PubMed ID: 9626234
    [No Abstract] [Full Text] [Related]

  • 20. Current approaches to the treatment of advanced-stage Hodgkin's disease.
    Rusthoven JJ.
    CMAJ; 1986 Sep 01; 135(5):465-73. PubMed ID: 2427176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.